S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
Rikki M. Tanner,David A. Calhoun,Emmy K. Bell,C. Barrett Bowling,Orlando M. Gutiérrez,Marguerite R. Irvin,Daniel T. Lackland,Suzanne Oparil,William McClellan,David G. Warnock,Paul Muntner +10 more
TL;DR: Individuals with treatment-resistant hypertension are at increased risk for end-stage renal disease (ESRD) and Appropriate clinical management strategies are needed to preserve kidney function in this high-risk group.
Journal ArticleDOI
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure
TL;DR: Patients with difficult-to-treat hypertension who fail to achieve target blood pressure on maximal antihypertensive therapy may benefit from special diagnostic and therapeutic considerations, including referral to a hypertension specialist.
Journal ArticleDOI
Estrogen Effects on Vascular Inflammation Are Age Dependent Role of Estrogen Receptors
Meaghan R. Bowling,Dongqi Xing,Akash Kapadia,Yiu-Fai Chen,Alexander J. Szalai,Suzanne Oparil,Fadi G. Hage +6 more
TL;DR: In this article, 17β-Estradiol (E2) pretreatment of young mice attenuated C-reactive protein (CRP)-induced expression of inflammatory mediators.
Journal ArticleDOI
Gender and Dietary NaCl in Spontaneously Hypertensive and Wistar-Kyoto Rats
TL;DR: The effects of high dietary NaCl exposure on diurnal variation of mean arterial pressure and heart rate in male and female SHR and WKY were evaluated using a telemetry monitoring system.
Journal ArticleDOI
Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines
Rachel G. Sinkey,Ashley N. Battarbee,Natalie A. Bello,Christopher W. Ives,Suzanne Oparil,Alan T.N. Tita +5 more
TL;DR: There are differences among international HDP guidelines related to dose and timing of aspirin initiation, thresholds for antihypertensive medication initiation, and BP targets, however, all guidelines acknowledge the significant morbidity associated with HDP and advocate for timely diagnosis and management to reduce associated morbidity and mortality.